Loading ...
Sorry, an error occurred while loading the content.

16486National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C

Expand Messages
  • scarletpaolicchi
    Sep 2, 2009
      National Summit on Viral Hepatitis to be Held September 10-11 in Washington,
      Tue Sep 1, 2009 11:26am EDT

      Politicians, Medical Experts and Community Advocates Will Gather for 2-Day
      Conference to Develop Action Plan to Combat Hepatitis B and C in the United

      WASHINGTON, Sept. 1 /PRNewswire/ --

      WHAT: Chronic viral hepatitis is a leading cause of liver cancer and
      cirrhosis that costs the nation's health system hundreds of
      millions of dollars each year, yet attracts little public
      attention. As many as 2 million people in the United States are
      living with chronic hepatitis B and an estimated 3.2 million are
      chronically infected with hepatitis C. However, most do not even
      know they are infected and miss out on getting early medical care,
      putting them at increased risk for developing serious liver

      To address this public health challenge, government, medical and
      community experts will meet September 10-11 in Washington, D.C. to
      plan an improved national response to viral hepatitis. The
      conference "The Dawn of a New Era: Transforming our Domestic
      Response to Hepatitis B & C" will feature keynote addresses, panel
      discussions and scientific poster sessions focused on enhancing
      the prevention and detection of viral hepatitis and improving care
      for people who are already living with the disease.

      Journalists are encouraged to participate in all aspects of the
      summit, and will enjoy unprecedented access to leading experts on
      viral hepatitis. A press room will be available.

      WHO: Speakers include:

      -- John W. Ward, MD, Director, U.S. Centers for Disease Control
      and Prevention (CDC) Division of Viral Hepatitis
      -- Congressman Mike Honda (D-CA), Chair, Congressional Asian
      Pacific American Caucus
      -- Congressman Bill Cassidy, MD (R-LA), Gastroenterologist and
      Associate Professor of Medicine, Louisiana State University
      Health Sciences Center
      -- Anna S.F. Lok, MD, Director of Clinical Hepatology, University
      of Michigan
      -- Eugene R. Schiff, MD, Director, Center for Liver Diseases,
      University of Miami School of Medicine
      -- Ronald O. Valdiserri, MD, MPH, U.S. Department of Veterans
      -- Jeff Caballero, Executive Director, Association of Asian
      Pacific Community Health Organizations

      Sponsors and supporters of the summit meeting include the Centers for
      Disease Control and Prevention (CDC), the National Institute of Allergy
      and Infectious Diseases, the American Gastroenterological Association's
      AGA Institute, the U.S. Department of Veterans Affairs, Gilead Sciences,
      Bristol-Myers Squibb and Vertex Pharmaceuticals.

      WHEN: September 10-11, 2009
      (Opening Keynote Address begins at 8 A.M. on Thursday, September

      WHERE: Washington Marriott Wardman Park Hotel
      2660 Woodley Road NW (between 27th St. and Connecticut Ave)
      Washington, DC 20008

      RSVP: Registration is free for media. To register for the conference,
      to schedule interviews or for more information please contact:

      Lauren Graham
      (212) 584-5015

      -- The hepatitis B virus is up to 100 times more infectious than HIV and
      causes up to 80 percent of liver cancer cases worldwide, making it
      second only to tobacco as a cancer-causing agent in humans.
      -- Chronic infection with the hepatitis C virus is the most common reason
      for liver transplantation among adults in the United States.
      -- More than $1 billion is spent each year on hospitalizations related to
      hepatitis B, and hepatitis C is responsible for more than $600 million
      annually in medical costs and lost productivity.

      -- Public awareness about viral hepatitis is low; too few physicians
      conduct routine screening and many patients are not benefiting from
      improved treatment options.

      More Hepatitis C events at